Bharat Biotech to resume exports of Covaxin

  • On Monday, COVID-19 vaccine-maker Bharat Biotech announced that the company has resumed the export of its COVID-19 vaccine Covaxin.

  • The company will start exporting in December 2021.

  • Covaxin is 78% effective against severe cases of COVID-19.


D9D318A1-A861-4CFD-94ED-B72F5EDD67F3_edi

Subscribe to us

Thanks for submitting!

intern%20with%20us_edited.jpg
  • Instagram
  • Twitter
  • LinkedIn
  • Facebook

INDEPENDENT.

OBJECTIVE.

UNBIASED. 

the breif bulletin logo